Neglected tropical diseases

Neglected zoonotic diseases (NZD)

From concept to completion: demonstrating feasibility, cost–effectiveness and benefits to human health from elimination of canine rabies

Canine and human rabies
Kevin LeRoux (South Africa)

Three countries known to have a high prevalence of canine rabies began rabies pilot projects in 2009: South Africa; the United Republic of Tanzania; and the Philippines. When the projects started, countries began at different stages to make impressive progress lessons were learnt from one another and they are now eager to embark on and contribute to achieving zero human rabies deaths by 2030 caused by dog-transmitted rabies.

Two new centres of excellence have joined the WHO network of Collaborating Centres for echinococcosis

© V. Lambert, Arhangay, Mongolia
Echinococcosis: a parasitic disease that occurs
in two main forms in humans: cystic echinococcosis
and alveolar echinococcosis

09 September 2016 | Geneva –– The World Health Organization (WHO) has expanded its network of collaborating centres for echinococcosis.

The latest two centres in Xinjiang, China and in Rome, Italy will help sustain control strategies and the implementation of uniform operational procedures, testing and training.

Advancing control of Taenia solium taeniasis and (neuro) cysticercosis

Free-roaming sow and piglets, Jaipur, India © Niall Corbet

02 June 2016 | Geneva -- T. solium-induced neurocysticercosis is a global public health problem with important socioeconomic impacts. Neurocysticercosis, the cause of serious, potentially lethal health conditions such as epilepsy, remains an under-recognized public health concern.

Two new documents are now available:
- Rationale for investment and action: Taenia solium infection burdens economies, societies and individuals
-Taenia solium taeniasis/cysticercosis diagnostic tools: Report of a stakeholder meeting

Human rabies: better coordination and emerging technology to improve access to vaccines

© Anne-Marie Labouche/ WHO

28 September 2016 ¦ Geneva –– The World Health Organization (WHO) is collaborating with partners, stakeholders and agencies to ensure a continued supply of human and dog vaccines and rabies immunoglobulins to sustain global efforts to eliminate human rabies by 2030.
WHO is also closely following the potential benefits that convergent technology can bring to facilitate the delivery of vaccines and immunoglobulins to remote rabies endemic areas and regions.

Most recent publications on NZD

Quick links